The phrase "a faster turnaround time" is correct and usable in written English.
You can use it when discussing the speed at which a task or process is completed, often in a business or project management context.
Example: "Our new strategy aims to ensure a faster turnaround time for client requests, improving overall satisfaction."
Alternatives: "quicker response time" or "reduced processing time."
Lighter transportation demands would mean more environmental benefits and a faster turnaround time, not to mention reduced shipping costs.
Working from home without the distractions of a shop has meant a faster turnaround time for orders, and Royle says she has found she can spend more time focusing on targeted sales and marketing.
"Industry usually needs a faster turnaround time than academia, so we're streamlining because we think that it will better serve the fellows and Canadian industry--as well as make the IRF more popular in general," Russwurm adds.
Information will be accessed more efficiently and patients will be treated more efficiently, so there's a faster turnaround time.
As in other viral infections, the adoption of standardized serological testing on high-volume automated systems will guarantee a faster turnaround time.
The PCR assay can reliably be performed on FFPE samples and has a faster turnaround time than current IDH mutation detection algorithms.
The use of material published over the course of the campaign points to another advantage of digital books: a fast turnaround time.
Another basic principle is to provide a peer review process that is both decisive and fair to authors, with a focus of a fast turnaround time.
Priority is given to the most recent publications, ensuring that InnateDB has a fast turnaround time for incorporating new information on the most current research into the database.
The adoption of articular cartilage calcification as a surrogate marker of OA disease, coupled with the development of improved detection methods for BCP crystals, could enable trials of targeted anti-crystal therapies with biological endpoints and a fast turnaround time.
We also found that the advantages included scalability according to patient volumes, moderate material costs (∼$250 per patient sample run for MiSeq TSACP, excluding tissue processing and labour; see Supplementary Table 2), and a fast turnaround time with a median tissue receipt to reporting of results of 5 days.
